Related Articles
An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer
Oncolytic herpes simplex virus and temozolomide synergistically inhibit breast cancer cell tumorigenesis <em>in vitro</em> and <em>in vivo</em>
Oncolytic herpes simplex virus treatment of metastatic breast cancer
Multiple strategies to improve the therapeutic efficacy of oncolytic herpes simplex virus in the treatment of glioblastoma (Review)
Estrogen enhances the efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor-positive breast cancer